RKDA Share Price Performance
US$3.53
-0.39 (-9.83%)
70.6% undervalued intrinsic discount
US$12.00
Fair Value
Price US$3.53
AnalystConsensusTarget US$12.00
Fair ValueUS$12.00
Share PriceUS$3.53
70.6% undervalued intrinsic discount
Arcadia Biosciences, Inc. Stock Price
- 1 Narratives written by author
- 1 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
RKDA Community Narratives
AN
Fair Value US$12 69.9% undervalued intrinsic discount
Zola Distribution Expansion Will Unlock Enduring Market Strength
0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
Zola Distribution Expansion Will Unlock Enduring Market Strength
Key Takeaways Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales. Strategic exits and IP monetization simplify operations, reduce expenses, and provide capital for growth, enhancing long-term financial stability.Read more
0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
AN
US$12
69.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
25.04% p.a.
Profit Margin
6.21%
Future PE
22.25x
Share price in 2028
US$10.64
Snowflake Analysis
Arcadia Biosciences, Inc. Key Details
About RKDA
- Founded
- 2002
- Employees
- 9
- CEO
- WebsiteView website
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
